Gastroesophageal reflux disease in noncardiac chest pain

Gastroenterology Clinics of North America

Volumn 33, Issue 1, 2004, Pages 41-54

  Faybush, Elisa M ^a,b   Fass, Ronnie ^a,b  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ANTIREFLUX OPERATION; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HEART; HEARTBURN; HUMAN; NONCARDIAC CHEST PAIN; PATHOPHYSIOLOGY; PH; POPULATION RESEARCH; PREVALENCE; REFLUX ESOPHAGITIS; REVIEW; SIDE EFFECT; STOMACH FUNDOPLICATION; SUBSTERNAL PAIN; THORAX PAIN;

CHEST PAIN; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 1642279298     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00131-6     Document Type: Review

References (51)

1. Locke G.R. III, Talley N.J., Fett S.L., Zinsmeister A.R., Melton L.J. III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 112:1997;1448-1456.
2. Eslick G.D., Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin N Am. 32:2003;531-552.
3. Richter J.E. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol. 30:(Suppl):2000;S39-S41.
4. Eslick G.D., Jones M.P., Talley N.J. Non-cardiac chest pain: prevalence, risk factors, impact and consulting: a population-based study. Aliment Pharmacol Ther. 17:2003;1115-1124.
5. Fass R., Winters G.F. Evaluation of the patient with noncardiac chest pain: is gastroesophageal reflux disease or an esophageal motility disorder the cause? Medscape Gastroenterol eJournal. 3:2001;1-7.
6. Cherian P., Smith L.F., Bardhan K.D., Thorpe J.A.C., Oakley G.D., Dawson D. Esophageal tests in the evaluation of non-cardiac chest pain. Dis Esophagus. 8:1995;129-133.
7. Fass R., Fennerty M.B., Ofman J.J., Gralnek I.M., Johnson C., Camargo E., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 115:1998;42-49.
8. Hsia P.C., Maher K.A., Lewis J.H., Cattau E.L. Jr., Fleischer D.E., Benjamin S.B. Utility of upper endoscopy in the evaluation of noncardiac chest pain. Gastrointest Endosc. 37:1991;22-26.
9. Frobert O., Funch-Jensen P., Jacobsen N.O., Kruse A., Bagger J.P. Upper endoscopy in patients with angina and normal coronary angiograms. Endoscopy. 27:1995;365-370.
10. Fass R., Naliboff B., Higa L., Johnson C., Kodner A., Munakata J., et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 115:1998;1363-1373.
11. Beedassy A., Katz P.O., Gruber A., Peghini P.L., Castell D.O. Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain. J Clin Gastroenterol. 31:2000;121-124.
12. Dekel, R., Martinez-Hawthorne, S.D., Guillen, R.J., Fass, R., Evaluation of symptom index (SI) in identifying gastroesophageal reflux disease (GERD)-related noncardiac chest pain (NCCP). J Clin Gastroenterol, in press.
13. Richter J.E. Extraesophageal presentations of gastroesophageal reflux disease: an overview. Am J Gastroenterol. 95:(Suppl):2000;S1-S3.
14. Wong W.M., Lai K.C., Lau C., Hu W.H., Chen W.H., Wong B.C., et al. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment Pharmacol Ther. 16:2002;465-471.
15. Chauhan A., Petch M.C., Schofield P.M. Cardio-oesophageal reflex in humans as a mechanism for "linked angina" Eur Heart J. 17:1996;407-413.
16. Rosztoczy A.I., Vass A., Wittmann T., Forster T., Csanady M., Rudas L., et al. Esophageal acid stimulation combined with transesophageal echocardiography shows high clinical impact in the establishment of esophago-cardiac reflex. Gastroenterology. 124:(Suppl):2003;A534.
17. Smith J.L., Opekun A.R., Larkai E., Graham D.Y. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 96:1989;683-689.
18. Hollerbach S., Bulat R., May A., Kamath M.V., Upton A.R.M., Fallen E.L., et al. Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP). Neurogastroenterol Motil. 12:2000;555-565.
19. Hu W.H., Martin C.J., Talley N.J. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 95:2000;2189-2194.
20. Sarkar S., Aziz Q., Woolf C.J., Hobson A.R., Thompson D.G. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet. 356:2000;1154-1159.
21. Tougas G., Spaziani R., Hollerbach S., Djuric V., Pang C., Upton A.R., et al. Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain. Gut. 49:2001;706-712.
22. Tougas G. The autonomic nervous system in functional bowel disorders. Gut. 47:(Suppl):2000;78-80.
23. Balaban D.H., Yamamoto Y., Liu J., Pehlivanov N., Wisniewski R., DeSilvey D., et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology. 116:1999;29-37.
24. Shrestha S., Pasricha P.J. Update on noncardiac chest pain. 18:2000;138-146.
25. Koch K.L., Davidson W.R. Jr., Day F.P., Spears P.F., Voss S.R. Esophageal dysfunction and chest pain in patients with mitral valve prolapse: a prospective study utilizing provocative testing during esophageal manometry. Am J Med. 86:1989;32-38.
26. Fass R., Ofman J.J., Sampliner R.E., Camargo L., Wendel C., Fennerty M.B. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-esophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther. 14:2000;389-396.
27. Xia H.H., Lai K.C., Lam S.K., Hu W.H., Wong N.Y., Hui W.M., et al. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther. 17:2003;369-377.
28. Garcia-Compean D., Gonzalez M.V., Galindo G., Mar D.A., Trevino J.L., Martinez R., et al. Prevalence of gastroesophageal reflux disease in patients with extraesophageal symptoms referred from otolaryngology, allergy, and cardiology practices: a prospective study. Dig Dis. 18:2000;178-182.
29. Johnston B.T., Troshinsky M.B., Castell J.A., Castell D.O. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 91:1996;1181-1185.
30. Fang J., Bjorkman D. A critical approach to noncardiac chest pain: pathophysiology, diagnosis, and treatment. Am J Gastroenterol. 96:2001;958-968.
31. Hewson E.G., Sinclair J.W., Dalton C.B., Richter J.E. Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Am J Med. 90:1991;576-583.
32. Pandolfino J.E., Richter J.E., Ours T., Guardino J.M., Chapman J., Kahrilas P.J. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 98:2003;740-749.
33. Fass R. Chest pain of esophageal origin. Curr Opin Gastroenterol. 18:2002;464-470.
34. Young M.F., Sanowski R.A., Talbert G.A., Harrison M.E., Walker B.E. Omeprezole administration as a test for gastroesophageal reflux. [abstract] Gastroenterology. 102:1992;192.
35. Squillace S.J., Young M.F., Sanowski R.A. Single dose omeprazole as a test for noncardiac chest pain. Gastroenterology. 104:1993;A197.
36. Fass R., Fullerton H., Hayden C.W., Garewal H.S. Patients with noncardiac chest pain (NCCP) receiving an empirical trial of high dose rabeprazole, demonstrate early symptom response - a double blind, placebo-controlled trial. Gastroenterology. 122:(Suppl 1):2002;A589-A590.
37. Fass R., Fennerty M.B., Johnson C., Camargo L., Sampliner R.E. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol. 28:1999;36-39.
38. Ofman J.J., Gralnek I.M., Udani J., Fennerty M.B., Fass R. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med. 107:1999;219-227.
39. Vela M.J., Camacho-Lobato L., Srinivasan R., Tutuian R., Katz P.O., Castell D.O. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 120:2001;1599-1606.
40. Storr M., Meining A., Allescher H.D. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Dig Dis. 18:2000;93-102.
41. Stahl W.G., Beton R.R., Johnson C.S., Brown C.L., Waring J.P. Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J. 87:1994;739-742.
42. DeMeester T.R., O'Sullivan G.C., Bermudez G., Midell A.I., Cimochowski G.E., O'Drobinak J. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg. 196:1982;488-498.
43. Jones R., Bytzer P. Acid suppression in the management of gastro-oesophageal reflux disease: an appraisal of treatment options in primary care. Aliment Pharmacol Ther. 15:2001;765-772.
44. Fass R., Malagon I., Schmulson M. Chest pain of esophageal origin. Curr Opin Gastroenterol. 17:2001;376-380.
45. Borzecki A.M., Pedrosa M.C., Prashker M.J. Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis. Arch Intern Med. 160:2000;844-852.
46. Patti M.G., Molena D., Fisichella P.M., Perretta S., Way L.W. Gastroesophageal reflux disease (GERD) and chest pain: results of laparoscopic antireflux surgery. Surg Endosc. 16:2002;563-566.
47. Farrell T.M., Richardson W.S., Trus T.L., Smith C.D., Hunter J.G. Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg. 88:2001;1649-1652.
48. Moss S.F., Armstrong D., Arnold R., Ferenci P., Fock K., Holtmann G., et al. GERD 2003: a consensus on the way ahead. Digestion. 67:2003;111-117.
49. Waring J.P. Surgical and endoscopic treatment of gastroesophageal reflux disease. Gastroenterol Clin N Am. 31:(Suppl):2002;S89-S109.
50. Fass R., Pulliam G., Hayden C.W. Patients with non-cardiac chest pain (NCCP) receiving an empirical trial of high dose lansoprazole, demonstrate early symptom response: a double blind, placebo-controlled trial. Gastroenterology. 120:(Suppl 1):2001;A221.
51. Pandak W.M., Arezo S., Everett S., Jesse R., DeCosta G., Crofts T., et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 35:2002;307-314.